EIR Intrinsic Therapeutics Mar 2017

Karen Kosar FDA$595.00 - Available Now

FDA investigators audited the Intrinsic Therapeutics - Woburn, MA, United States facility and issued inspectional observation (via FDA 483) on 31 Mar 2017.

Product details

  • Category:
  • Inspection end: 31 Mar 2017
  • Location: Woburn, United States
  • FEI: 3006232063
Add To Cart